ES2523518T3 - Nuevas combinaciones farmacológicas para el tratamiento de enfermedades de las vías respiratorias - Google Patents

Nuevas combinaciones farmacológicas para el tratamiento de enfermedades de las vías respiratorias Download PDF

Info

Publication number: ES2523518T3
Authority: ES; Spain
Prior art keywords: treatment; respiratory diseases; new pharmacological; pharmacological combinations; hydroxy
Prior art date: 2004-04-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

ES11187038.2T

Other languages

English (en)

Spanish (es)

Inventor

Thierry Bouyssou

Ingo Konetzki

Sabine Pestel

Andreas Schnapp

Christoph Hoenke

Philipp Lustenberger

Klaus Rudolf

Michael P. Pieper

Michel Pairet

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim International GmbH

Original Assignee

Boehringer Ingelheim International GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-22

Filing date

2005-04-18

Publication date

2014-11-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2523518(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-04-22 Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/de

2004-11-03 Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/de

2005-04-18 Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH

2014-11-26 Application granted granted Critical

2014-11-26 Publication of ES2523518T3 publication Critical patent/ES2523518T3/es

2025-04-18 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

230000000144 pharmacologic effect Effects 0.000 title abstract 2
208000023504 respiratory system disease Diseases 0.000 title 1
239000002253 acid Substances 0.000 abstract 2
150000007513 acids Chemical class 0.000 abstract 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
229960003728 ciclesonide Drugs 0.000 abstract 1
229940125904 compound 1 Drugs 0.000 abstract 1
150000004677 hydrates Chemical class 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
COUYJEVMBVSIHV-UHFFFAOYSA-N olodaterol Chemical compound C1=CC(OC)=CC=C1CC(C)(C)NCC(O)C1=CC(O)=CC2=C1OCC(=O)N2 COUYJEVMBVSIHV-UHFFFAOYSA-N 0.000 abstract 1
230000003287 optical effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical class O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Tropical Medicine & Parasitology (AREA)
Transplantation (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ES11187038.2T 2004-04-22 2005-04-18 Nuevas combinaciones farmacológicas para el tratamiento de enfermedades de las vías respiratorias Expired - Lifetime ES2523518T3 (es)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
DE102004019540		2004-04-22
DE102004019540A DE102004019540A1 (de)	2004-04-22	2004-04-22	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE102004052987		2004-11-03
DE102004052987A DE102004052987A1 (de)	2004-11-03	2004-11-03	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EP05002496		2005-02-07
EP05002496		2005-02-07

Publications (1)

Publication Number	Publication Date
ES2523518T3 true ES2523518T3 (es)	2014-11-26

Family

ID=34966478

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ES11187038.2T Expired - Lifetime ES2523518T3 (es)	2004-04-22	2005-04-18	Nuevas combinaciones farmacológicas para el tratamiento de enfermedades de las vías respiratorias
ES05739576T Expired - Lifetime ES2380370T3 (es)	2004-04-22	2005-04-18	Combinaciones farmacológicas que contienen benzoxazina para el tratamiento de enfermedades de las vías respiratorias

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
ES05739576T Expired - Lifetime ES2380370T3 (es)	2004-04-22	2005-04-18	Combinaciones farmacológicas que contienen benzoxazina para el tratamiento de enfermedades de las vías respiratorias

Country Status (33)

Country	Link
EP (2)	EP1781298B1 (2)
JP (1)	JP2007533683A (2)
KR (2)	KR101287460B1 (2)
AR (1)	AR049262A1 (2)
AT (1)	ATE539754T1 (2)
AU (1)	AU2005235419B2 (2)
BE (1)	BE2015C065I2 (2)
BR (1)	BRPI0510080B8 (2)
CA (1)	CA2559699C (2)
CY (3)	CY1113890T1 (2)
DK (2)	DK2422786T3 (2)
EA (1)	EA013157B1 (2)
EC (1)	ECSP066947A (2)
ES (2)	ES2523518T3 (2)
FI (1)	FIC20170005I1 (2)
FR (1)	FR16C0029I2 (2)
HU (1)	HUS1500058I1 (2)
IL (2)	IL177685A (2)
LT (1)	LTC1781298I2 (2)
LU (1)	LU93066I2 (2)
MY (1)	MY148945A (2)
NL (1)	NL300779I2 (2)
NO (2)	NO337714B1 (2)
NZ (1)	NZ550797A (2)
PE (1)	PE20060462A1 (2)
PL (2)	PL1781298T4 (2)
PT (2)	PT2422786E (2)
SG (1)	SG152237A1 (2)
SI (2)	SI1781298T1 (2)
TW (2)	TWI374739B (2)
UY (1)	UY28861A1 (2)
WO (1)	WO2005102349A1 (2)
ZA (1)	ZA200606624B (2)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) *	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US7923455B2 (en) *	2005-01-28	2011-04-12	Boehringer Ingelheim International Gmbh	Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
EP1855689A1 (en) *	2005-02-16	2007-11-21	Boehringer Ingelheim International GmbH	Pharmaceutical compositions comprising anticholinergics and etiprednol
BRPI0614410A2 (pt)	2005-08-15	2011-03-29	Boehringer Ingelheim Int	processo para preparação de betamiméticos
US20070088030A1 (en)	2005-10-10	2007-04-19	Barbara Niklaus-Humke	Aerosol formulations for the inhalation of beta-agonists
US20070086957A1 (en)	2005-10-10	2007-04-19	Thierry Bouyssou	Combination of medicaments for the treatment of respiratory diseases
ATE529399T1 (de) *	2005-11-10	2011-11-15	Nicholas S Bodor	Sanfte anticholinerge ester
EP1986644A1 (de) *	2006-02-16	2008-11-05	Boehringer Ingelheim International GmbH	Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
CA2660186A1 (en) *	2006-08-07	2008-02-14	Boehringer Ingelheim International Gmbh	Pharmaceutical combinations for the treatment of respiratory diseases
UY30543A1 (es) *	2006-08-18	2008-03-31	Boehringer Ingelheim Int	Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) *	2006-08-18	2008-03-31	Boehringer Ingelheim Int	Formulacion de aerosol para la inhalacion de agonistas beta
US20100099651A1 (en) *	2006-10-26	2010-04-22	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
EP1921070A1 (de)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
US8497369B2 (en)	2008-02-07	2013-07-30	Boehringer Ingelheim International Gmbh	Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production
EP2313397B1 (de)	2008-08-08	2016-04-20	Boehringer Ingelheim International GmbH	Cyclohexyloxy-substituierte heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
JP2012509922A (ja) *	2008-11-27	2012-04-26	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規粉末化結晶質吸入薬
WO2014016548A2 (en) *	2012-07-27	2014-01-30	Cipla Limited	Pharmaceutical composition
WO2014056840A1 (en)	2012-10-09	2014-04-17	Boehringer Ingelheim International Gmbh	Beta-2-adrenoceptor agonist for the treatment of cough

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4460581A (en) *	1982-10-12	1984-07-17	Boehringer Ingelheim Kg	(1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en)	1983-08-03	1986-02-18	Miles Laboratories, Inc.	Medicament inhalation device
AU591152B2 (en)	1985-07-30	1989-11-30	Glaxo Group Limited	Devices for administering medicaments to patients
SE453566B (sv)	1986-03-07	1988-02-15	Draco Ab	Anordning vid pulverinhalatorer
SG45171A1 (en)	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
DE4318455A1 (de)	1993-06-03	1994-12-08	Boehringer Ingelheim Kg	Kapselhalterung
DE19536902A1 (de)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
SK15382002A3 (sk) *	2000-04-27	2003-03-04	Boehringer Ingelheim Pharma Kg	Betamimetiká, farmaceutický prostriedok s ich obsahom a ich použitie
WO2002030928A1 (de)	2000-10-12	2002-04-18	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
ME00412B (me)	2001-06-22	2011-10-10	Boehringer Ingelheim Pharma	Kristalni antiholinergik , postupak za njegovo pripremanje i njegova primjena u proizvodnji lijeka
DE10130371A1 (de) *	2001-06-23	2003-01-02	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2203327B1 (es) *	2002-06-21	2005-06-16	Almirall Prodesfarma, S.A.	Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
DE10230751A1 (de) *	2002-07-09	2004-01-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10246374A1 (de) *	2002-10-04	2004-04-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253282A1 (de) *	2002-11-15	2004-05-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

2005
- 2005-04-18 DK DK11187038.2T patent/DK2422786T3/da active
- 2005-04-18 EP EP05739576A patent/EP1781298B1/de not_active Expired - Lifetime
- 2005-04-18 EA EA200601846A patent/EA013157B1/ru active Protection Beyond IP Right Term
- 2005-04-18 CA CA2559699A patent/CA2559699C/en not_active Expired - Fee Related
- 2005-04-18 AU AU2005235419A patent/AU2005235419B2/en active Active
- 2005-04-18 SI SI200531488T patent/SI1781298T1/sl unknown
- 2005-04-18 SG SG200902525-5A patent/SG152237A1/en unknown
- 2005-04-18 PT PT111870382T patent/PT2422786E/pt unknown
- 2005-04-18 PL PL05739576T patent/PL1781298T4/pl unknown
- 2005-04-18 WO PCT/EP2005/004073 patent/WO2005102349A1/de not_active Ceased
- 2005-04-18 KR KR1020067024528A patent/KR101287460B1/ko not_active Expired - Lifetime
- 2005-04-18 DK DK05739576.6T patent/DK1781298T3/da active
- 2005-04-18 BR BRPI0510080A patent/BRPI0510080B8/pt active IP Right Grant
- 2005-04-18 KR KR1020137011141A patent/KR20130049840A/ko not_active Ceased
- 2005-04-18 PT PT05739576T patent/PT1781298E/pt unknown
- 2005-04-18 SI SI200531904T patent/SI2422786T1/sl unknown
- 2005-04-18 ES ES11187038.2T patent/ES2523518T3/es not_active Expired - Lifetime
- 2005-04-18 ES ES05739576T patent/ES2380370T3/es not_active Expired - Lifetime
- 2005-04-18 EP EP11187038.2A patent/EP2422786B1/de not_active Expired - Lifetime
- 2005-04-18 PL PL11187038T patent/PL2422786T3/pl unknown
- 2005-04-18 AT AT05739576T patent/ATE539754T1/de active
- 2005-04-18 JP JP2007508805A patent/JP2007533683A/ja active Pending
- 2005-04-18 NZ NZ550797A patent/NZ550797A/en not_active IP Right Cessation
- 2005-04-19 UY UY28861A patent/UY28861A1/es not_active Application Discontinuation
- 2005-04-20 MY MYPI20051739A patent/MY148945A/en unknown
- 2005-04-20 PE PE2005000432A patent/PE20060462A1/es active IP Right Grant
- 2005-04-21 TW TW101108945A patent/TWI374739B/zh not_active IP Right Cessation
- 2005-04-21 TW TW094112735A patent/TWI372056B/zh active
- 2005-04-22 AR ARP050101601A patent/AR049262A1/es not_active Application Discontinuation
2006
- 2006-08-08 ZA ZA2006/06624A patent/ZA200606624B/en unknown
- 2006-08-24 IL IL177685A patent/IL177685A/en active IP Right Grant
- 2006-10-23 EC EC2006006947A patent/ECSP066947A/es unknown
- 2006-11-02 NO NO20065060A patent/NO337714B1/no active Protection Beyond IP Right Term
2012
- 2012-03-26 CY CY20121100308T patent/CY1113890T1/el unknown
2013
- 2013-05-26 IL IL226562A patent/IL226562A0/en unknown
2014
- 2014-11-07 CY CY20141100925T patent/CY1115719T1/el unknown
2015
- 2015-12-01 LT LTPA2015043C patent/LTC1781298I2/lt unknown
- 2015-12-01 BE BE2015C065C patent/BE2015C065I2/fr unknown
- 2015-12-01 HU HUS1500058C patent/HUS1500058I1/hu unknown
- 2015-12-01 NL NL300779C patent/NL300779I2/nl unknown
2016
- 2016-05-09 LU LU93066C patent/LU93066I2/fr unknown
- 2016-06-22 FR FR16C0029C patent/FR16C0029I2/fr active Active
- 2016-12-01 NO NO2016022C patent/NO2016022I1/no unknown
2017
- 2017-01-13 FI FIC20170005C patent/FIC20170005I1/fi unknown
- 2017-04-20 CY CY2017014C patent/CY2017014I1/el unknown

Also Published As

Publication number	Publication date
UY28861A1 (es)	2005-11-30
PT1781298E (pt)	2012-02-03
EA200601846A1 (ru)	2007-04-27
TW201231055A (en)	2012-08-01
DK2422786T3 (da)	2014-11-17
FR16C0029I2 (fr)	2017-01-27
PL2422786T3 (pl)	2015-02-27
LTC1781298I2 (lt)	2018-09-25
CA2559699A1 (en)	2005-11-03
NZ550797A (en)	2010-08-27
IL226562A0 (en)	2013-06-27
ES2380370T3 (es)	2012-05-11
FIC20170005I1 (fi)	2017-01-13
FR16C0029I1 (2)	2016-08-26
AR049262A1 (es)	2006-07-12
IL177685A0 (en)	2006-12-31
BRPI0510080A (pt)	2007-10-16
SI1781298T1 (sl)	2012-04-30
MY148945A (en)	2013-06-14
CY1113890T1 (el)	2016-07-27
EP1781298B1 (de)	2012-01-04
EP2422786A1 (de)	2012-02-29
NO2016022I2 (no)	2016-12-01
NL300779I2 (nl)	2017-11-02
LU93066I2 (fr)	2016-07-11
HUS1500058I1 (hu)	2016-01-28
BE2015C065I2 (2)	2024-08-08
PL1781298T3 (pl)	2012-06-29
WO2005102349A1 (de)	2005-11-03
DK1781298T3 (da)	2012-05-07
IL177685A (en)	2013-10-31
BRPI0510080B1 (pt)	2020-08-18
EP1781298A1 (de)	2007-05-09
NO2016022I1 (no)	2016-12-01
AU2005235419A1 (en)	2005-11-03
BRPI0510080B8 (pt)	2021-05-25
CY1115719T1 (el)	2017-01-25
ATE539754T1 (de)	2012-01-15
ECSP066947A (es)	2007-01-26
CY2017014I2 (el)	2017-11-14
CA2559699C (en)	2012-06-19
PE20060462A1 (es)	2006-06-19
SG152237A1 (en)	2009-05-29
KR101287460B1 (ko)	2013-07-23
ZA200606624B (en)	2008-01-08
NO337714B1 (no)	2016-06-06
EP2422786B1 (de)	2014-08-13
TWI372056B (en)	2012-09-11
JP2007533683A (ja)	2007-11-22
KR20130049840A (ko)	2013-05-14
PT2422786E (pt)	2014-11-12
TWI374739B (en)	2012-10-21
SI2422786T1 (sl)	2014-12-31
KR20070015592A (ko)	2007-02-05
PL1781298T4 (pl)	2017-07-31
NO20065060L (no)	2006-11-21
EA013157B1 (ru)	2010-02-26
AU2005235419B2 (en)	2010-11-04
CY2017014I1 (el)	2017-11-14

Publication	Publication Date	Title
ES2523518T3 (es)	2014-11-26	Nuevas combinaciones farmacológicas para el tratamiento de enfermedades de las vías respiratorias
MX2009001659A (es)	2009-04-23	Compuestos de 2,5-dihidroxibenceno para el tratamiento de rosacea.
PA8680701A1 (es)	2007-01-17	Derivados de oxindol
UY29199A1 (es)	2006-06-30	Derivados tiazol, composiciones que los contienen, procedimientos de preparación y aplicaciones
NI200300042A (es)	2005-11-01	Compuestos que modulan la actividad de ppar y metodos para su preparacion.
SV2010003567A (es)	2010-09-13	Derivados bis-(sulfonilamino) en terapia 066
AR059948A1 (es)	2008-05-14	Formas farmaceuticas y metodos de tratamiento que usan un inhibidor de la tirosinacinasa
AR079208A2 (es)	2012-01-04	Inhibidores de la actividad de proteina tirosina quinasa, composicion y uso de dichos inhibidores para la preparacion de un medicamento para tratar una enfermedad, trastorno o condicion oftalmica
UY31468A1 (es)	2009-07-17	Derivados bis-(sulfonilamino) en terapia 065
ECSP034848A (es)	2003-12-24	Derivados oxazol acido carboxilico sustituidos para uso como activadores ppar-alpha y -gamma en el tratamiento de diabetes
PA8587101A1 (es)	2004-09-16	Nuevos derivados de dihidropirimido [4,5-d] pirimidinona sustituida por amiino, fabricacion y uso de los mismos como agentes farmaceuticos
ES2376043T3 (es)	2012-03-08	Derivados de indazol para el tratamiento de enfermedades inducidas por hsp90.
AR058163A1 (es)	2008-01-23	Medicamentos exhaltadores del deseo sexual que comprenden derivados de benzimidazolona
AR062401A1 (es)	2008-11-05	Uso de derivados del 2,5-dihidroxibenceno para tratar dermatitis
AR062395A1 (es)	2008-11-05	Uso de derivados del 2.5-dihidroxibenceno para el tratamiento de enfermedades oculares
MX2021012904A (es)	2022-01-18	Moduladores de la via de respuesta al estres integrada.
AR029412A1 (es)	2003-06-25	Forma cristalina
AR024998A1 (es)	2002-11-06	Nuevos retinoides para el tratamiento del enfisema
UY37445A (es)	2018-05-31	Derivados novedosos de napitridinona y su uso en el tratamiento de la arritmia
MX382978B (es)	2025-03-12	Método para tratar enfermedades de los ojos asociadas con inflamación o proliferación vascular.
MX390507B (es)	2025-03-20	Compuestos de amida y su uso.
AR053135A1 (es)	2007-04-25	Compuestos betamimeticos eficaces a largo plazo para el tratamiento de enfermedades respiratorias
MX2019012088A (es)	2020-02-07	Combinacion de antagonista nk1 y metodo para tratar sinucleinopatias.
AR026704A1 (es)	2003-02-26	Forma cristalina
UY37745A (es)	2019-01-02	Compuestos bicíclicos 5,6 fusionados y composiciones para el tratamiento de las enfermedades parasitarias